Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Tofacitinib“
Suchtreffer
Begriffe & Kennungen
Xeljanz · 4.8 · The incidence rates (95% CI) for serious infections for tofacitinib 5 mg twice daily, tofacitinib 10 mg twice
Eintrag öffnenXeljanz · 4.8 · The incidence rates (95% CI) for serious infections for tofacitinib 5 mg twice daily, tofacitinib 10 mg twice
Eintrag öffnenXeljanz · 4.8 · The incidence rates (95% CI) for serious infections for tofacitinib 5 mg twice daily, tofacitinib 10 mg twice
Eintrag öffnenXeljanz · 4.8 · The overall incidence rate of infections with tofacitinib in the long-term safety all exposure population (tot
Eintrag öffnenXeljanz · 4.8 · The overall incidence rate of infections with tofacitinib in the long-term safety all exposure population (tot
Eintrag öffnenXeljanz · 4.8 · Ulcerative colitis The most commonly reported adverse reactions in patients receiving tofacitinib 10 mg twice
Eintrag öffnenXeljanz · 4.8 · Upon withdrawal of tofacitinib treatment, lipid levels returned to baseline.
Eintrag öffnenXeljanz · 4.8 · Upon withdrawal of tofacitinib treatment, lipid levels returned to baseline.
Eintrag öffnenXeljanz · 4.8 · • Mean LDL cholesterol increased by 13.80%, 17.04%, and 5.50% in patients receiving tofacitinib 5 mg twice dai
Eintrag öffnenXeljanz · 4.8 · • Mean LDL cholesterol increased by 13.80%, 17.04%, and 5.50% in patients receiving tofacitinib 5 mg twice dai
Eintrag öffnenXeljanz · 4.8 · • Mean LDL cholesterol increased by 13.80%, 17.04%, and 5.50% in patients receiving tofacitinib 5 mg twice dai
Eintrag öffnenXeljanz · 4.8 · • Mean LDL cholesterol increased by 15% in the tofacitinib 5 mg twice daily arm and 20% in the tofacitinib 10
Eintrag öffnenXeljanz · 4.8 · • Mean LDL cholesterol increased by 15% in the tofacitinib 5 mg twice daily arm and 20% in the tofacitinib 10
Eintrag öffnenXeljanz · 4.8 · • Mean LDL cholesterol increased by 15% in the tofacitinib 5 mg twice daily arm and 20% in the tofacitinib 10
Eintrag öffnentofacitinib
Eintrag öffnentofacitinib
Eintrag öffnen